{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:46:38Z","timestamp":1782434798354,"version":"3.54.5"},"reference-count":56,"publisher":"CSIRO Publishing","issue":"4","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,17]]},"abstract":"<jats:p>In Australia, opioid use disorder is a major public health concern, and opioid agonist treatment (OAT) is an effective and evidence-based approach for treating opioid use disorder, reducing morbidity, mortality and societal cost. In Australia, 60% of OAT prescribing occurs in general practice, but significant barriers exist. This scoping review aimed to find research describing the characteristics and evaluation of different models of primary care-based OAT in Australia. Following the PRISMA guidelines for scoping reviews, a systematic search was conducted of PubMed, Embase, Scopus and CINAHL, and several grey literature databases. We conducted a narrative synthesis, and derived study themes inductively from included studies. We identified 24 relevant articles over 34\u00a0years that reported primary research on general practice-based OAT. Seven studies evaluated general practice OAT; eight examined prescriber attitudes, behaviour and workforce; two described single-models of care; four investigated primary care OAT policy; and two studies examined consumer experiences. The studies showed primary care OAT was as effective as specialist care for retention in OAT; however, prescriber deficits exist, with lack of remuneration and stigma identified as common barriers. The multidisciplinary models of care all received external funding, with GPs well placed, but underfunded, to coordinate care. The limited research demonstrates research gaps in service delivery, models of care, funding and views of people who use drugs. Future research scope needs to be broadened to encompass improved national monitoring datasets, patient views, models of care, holistic support and coordination, and structural supports to recruit and retain active prescribers.<\/jats:p>","DOI":"10.1071\/py25274","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:56:48Z","timestamp":1782431808000},"source":"Crossref","is-referenced-by-count":0,"title":["A scoping review of opioid agonist treatment in Australian general practice"],"prefix":"10.1071","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-759X","authenticated-orcid":true,"given":"Warren","family":"Jennings","sequence":"first","affiliation":[{"name":"AGeneral Practice Clinical Unit, The University of Queensland, Herston, Qld 4006, Australia."},{"name":"BSouthern Queensland Centre of Excellence in Aboriginal and Torres Strait Islander Primary Health Care, Metro South Health, Queensland Health, Inala, Qld 4077, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idin","family":"Panahi","sequence":"additional","affiliation":[{"name":"CSchool of Public Health, The University of Queensland, Herston, Qld 4006, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Piatkowski","sequence":"additional","affiliation":[{"name":"DCentre for Health Services Research, University of Queensland, Herston, Qld 4006, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Wirtz","sequence":"additional","affiliation":[{"name":"EUniversity of Queensland Medical School, The University of Queensland, Herston, Qld 4006, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ting","sequence":"additional","affiliation":[{"name":"EUniversity of Queensland Medical School, The University of Queensland, Herston, Qld 4006, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Spurling","sequence":"additional","affiliation":[{"name":"AGeneral Practice Clinical Unit, The University of Queensland, Herston, Qld 4006, Australia."},{"name":"BSouthern Queensland Centre of Excellence in Aboriginal and Torres Strait Islander Primary Health Care, Metro South Health, Queensland Health, Inala, Qld 4077, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"2","key":"2026062519564422300_R1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/713659318","article-title":"GP attitudes to managing drug- and alcohol-dependent patients: a reluctant role.","volume":"19","author":"Abouyanni","year":"2000","journal-title":"Drug and Alcohol Review"},{"issue":"6","key":"2026062519564422300_R2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.31128\/AJGP-07-21-6098","article-title":"Retention rates with monthly depot buprenorphine in general practice in Melbourne, Australia.","volume":"51","author":"Andrada","year":"2022","journal-title":"Australian Journal of General Practice"},{"issue":"1","key":"2026062519564422300_R3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework.","volume":"8","author":"Arksey","year":"2005","journal-title":"International Journal of Social Research Methodology"},{"key":"2026062519564422300_R4","unstructured":"Australian Government (2025) Pharmaceutical benefits scheme: opioid dependence treatment program. Australian Government: Department of Health, Disability and Ageing, Canberra. Available at https:\/\/www.pbs.gov.au\/browse\/section100-md"},{"key":"2026062519564422300_R5","unstructured":"Australian Government Department of Health and Aged Care (2021) Summary of state and territory opioid dependence treatment programs - April 2021. Available at https:\/\/www.pbs.gov.au\/reviews\/post-market-review-of-opiate-dependence-treatment-program\/summary-of-state-and-territory-ODT-programs-April-2021.PDF"},{"key":"2026062519564422300_R6","unstructured":"Australian Institute of Health and Welfare (2023) National Opioid Pharmacotherapy Statistics Annual Data collection \u2014 Prescribers. Available at https:\/\/www.aihw.gov.au\/reports\/alcohol-other-drug-treatment-services\/national-opioid-pharmacotherapy-statistics\/contents\/opioid-pharmacotherapy-prescribers?request=smoothstate"},{"key":"2026062519564422300_R7","unstructured":"Australian Institute of Health and Welfare (2024) National Opioid Pharmacotherapy Statistics Annual Data collection. Australian Institute of Health and Welfare, Canberra. Available at https:\/\/www.aihw.gov.au\/reports\/alcohol-other-drug-treatment-services\/national-opioid-pharmacotherapy-statistics\/contents\/opioid-pharmacotherapy-prescribers [Verified December 2024]"},{"key":"2026062519564422300_R8","unstructured":"Australian Institute of Health and Welfare (2025) Stronger evidence, better decisions, improved health and welfare. Available at https:\/\/www.aihw.gov.au"},{"issue":"5","key":"2026062519564422300_R9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1753-6405.2007.00113.x","article-title":"An evaluation of opioid replacement pharmacotherapy in an urban Aboriginal Health Service.","volume":"31","author":"Black","year":"2007","journal-title":"Australian and New Zealand Journal of Public Health"},{"issue":"4","key":"2026062519564422300_R10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/16066359609005247","article-title":"Census of patients receiving methadone treatment in a general practice.","volume":"3","author":"Byrne","year":"1996","journal-title":"Addiction Research"},{"issue":"1","key":"2026062519564422300_R11","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-37","article-title":"Validation of the theoretical domains framework for use in behaviour change and implementation research.","volume":"7","author":"Cane","year":"2012","journal-title":"Implementation Science"},{"issue":"S7","key":"2026062519564422300_R12","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.5694\/mja16.00124","article-title":"The Partners in Recovery program: mental health commissioning using value co-creation.","volume":"204","author":"Cheverton","year":"2016","journal-title":"Medical Journal of Australia"},{"issue":"1","key":"2026062519564422300_R13","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02607-x","article-title":"Reframing conceptualizations of primary care involvement in opioid use disorder treatment.","volume":"25","author":"Chiu","year":"2024","journal-title":"BMC Primary Care"},{"issue":"1","key":"2026062519564422300_R14","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-021-01377-0","article-title":"How many general practice consultations occur in Ireland annually? Cross-sectional data from a survey of general practices.","volume":"22","author":"Collins","year":"2021","journal-title":"BMC Family Practice"},{"issue":"1","key":"2026062519564422300_R15","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00773-2","article-title":"Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study.","volume":"20","author":"Curtis","year":"2023","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"2026062519564422300_R16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/dar.14049","article-title":"Changing patterns of opioid agonist therapy prescribing in a network of specialised clinics providing care to people with opioid use disorder in Victoria, Australia, 2015 to 2023.","volume":"44","author":"Dawe","year":"2025","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"2026062519564422300_R17","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0272-4","article-title":"Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice.","volume":"16","author":"Delargy","year":"2019","journal-title":"Harm Reduction Journal"},{"issue":"10","key":"2026062519564422300_R18","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1111\/add.16268","article-title":"Prevalence of opioid dependence in New South Wales, Australia, 2014\u201316: indirect estimation from multiple data sources using a Bayesian approach.","volume":"118","author":"Downing","year":"2023","journal-title":"Addiction"},{"issue":"6","key":"2026062519564422300_R19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000506630","article-title":"Primary care of opioid use disorder: the end of \u201cthe French Model\u201d?","volume":"26","author":"Dupouy","year":"2020","journal-title":"European Addiction Research"},{"issue":"4","key":"2026062519564422300_R20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/09595239996284","article-title":"An evaluation of community methadone services in Victoria, Australia: results of a client survey.","volume":"18","author":"Ezard","year":"1999","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"2026062519564422300_R21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/dar.13345","article-title":"Coming of age: 21 years of providing opioid substitution treatment within an Aboriginal community-controlled primary health service.","volume":"41","author":"Freeburn","year":"2022","journal-title":"Drug and Alcohol Review"},{"issue":"5","key":"2026062519564422300_R22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.31128\/AJGP-11-24-7467","article-title":"Provision of a remote telehealth opioid substitution therapy clinic in a regional Victorian community.","volume":"54","author":"Garry","year":"2025","journal-title":"Australian Journal of General Practice"},{"issue":"1","key":"2026062519564422300_R23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5694\/j.1326-5377.2003.tb05417.x","article-title":"A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.","volume":"179","author":"Gibson","year":"2003","journal-title":"Medical Journal of Australia"},{"issue":"4","key":"2026062519564422300_R24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/09595239200185501","article-title":"Establishing a drug and alcohol service in an Australian rural area.","volume":"11","author":"Helliwell","year":"1992","journal-title":"Drug and Alcohol Review"},{"issue":"6","key":"2026062519564422300_R25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5694\/mja11.11338","article-title":"Waiting room ambience and provision of opioid substitution therapy in general practice.","volume":"196","author":"Holliday","year":"2012","journal-title":"Medical Journal of Australia"},{"issue":"5","key":"2026062519564422300_R26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/dar.12046","article-title":"An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy.","volume":"32","author":"Holliday","year":"2013","journal-title":"Drug and Alcohol Review"},{"issue":"5","key":"2026062519564422300_R27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/09595230500286013","article-title":"The general practitioner pharmacotherapy prescribing workforce: examining sustainability from a systems perspective.","volume":"24","author":"Hotham","year":"2005","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"2026062519564422300_R28","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01764-9","article-title":"Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials.","volume":"10","author":"Klimas","year":"2021","journal-title":"Systematic Reviews"},{"issue":"4","key":"2026062519564422300_R29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care-based models for the treatment of opioid use disorder: a scoping review.","volume":"166","author":"Korthuis","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"2026062519564422300_R30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186315","article-title":"Primary care models for treating opioid use disorders: what actually works? A systematic review.","volume":"12","author":"Lagisetty","year":"2017","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"2026062519564422300_R31","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1080\/10550490490440799","article-title":"Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial.","volume":"13","author":"Lintzeris","year":"2004","journal-title":"The American Journal on Addictions"},{"issue":"4","key":"2026062519564422300_R32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1465-3362.2010.00212.x","article-title":"Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation.","volume":"30","author":"Longman","year":"2011","journal-title":"Drug and Alcohol Review"},{"issue":"4","key":"2026062519564422300_R33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1071\/PY11100","article-title":"Reluctant to train, reluctant to prescribe: barriers to general practitioner prescribing of opioid substitution therapy.","volume":"18","author":"Longman","year":"2012","journal-title":"Australian Journal of Primary Health"},{"issue":"4","key":"2026062519564422300_R34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1071\/PY20288","article-title":"Termination of pregnancy in Tasmania: access and service provision from the perspective of GPs.","volume":"27","author":"Ogden","year":"2021","journal-title":"Australian Journal of Primary Health"},{"issue":"6","key":"2026062519564422300_R35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/dar.12979","article-title":"The lived experience of Australian opioid replacement therapy recipients in a community-based program in regional Victoria.","volume":"38","author":"Patil Vishwanath","year":"2019","journal-title":"Drug and Alcohol Review"},{"key":"2026062519564422300_R36","unstructured":"Penington Institute (2023) Opioid pharmacotherapy at the crossroads: enduring barriers and new opportunities. Penington Institute, Melbourne."},{"key":"2026062519564422300_R37","unstructured":"Penington Institute (2024) Australia\u2019s annual overdose report 2024. Penington Institute, Melbourne. Available at https:\/\/www.penington.org.au\/wp-content\/uploads\/2024\/08\/PEN_Annual-Overdose-Report-2024.pdf"},{"key":"2026062519564422300_R38"},{"issue":"10","key":"2026062519564422300_R39","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews.","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evidence Synthesis"},{"issue":"7","key":"2026062519564422300_R40","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/add.70009","article-title":"The world\u2019s first anabolic-androgenic steroid testing trial: a two-phase pilot combining chemical analysis, results dissemination and community feedback.","volume":"120","author":"Piatkowski","year":"2025","journal-title":"Addiction"},{"issue":"7","key":"2026062519564422300_R41","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/dar.13754","article-title":"Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: a time series analysis.","volume":"42","author":"Picco","year":"2023","journal-title":"Drug and Alcohol Review"},{"key":"2026062519564422300_R42"},{"issue":"3","key":"2026062519564422300_R43","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/dar.14008","article-title":"Unmet treatment need: the size of the gap for alcohol and other drugs in Australia.","volume":"44","author":"Ritter","year":"2025","journal-title":"Drug and Alcohol Review"},{"issue":"4","key":"2026062519564422300_R44","first-page":"241","article-title":"Opioid substitution therapy--a study of GP participation in prescribing.","volume":"40","author":"Scarborough","year":"2011","journal-title":"Australian Family Physician"},{"issue":"8930","key":"2026062519564422300_R45","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(94)90634-3","article-title":"Is primary care essential?","volume":"344","author":"Starfield","year":"1994","journal-title":"The Lancet"},{"issue":"515","key":"2026062519564422300_R46","first-page":"444","article-title":"The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.","volume":"55","author":"Strang","year":"2005","journal-title":"The British Journal of General Practice"},{"key":"2026062519564422300_R47","unstructured":"The Lowitja Institute (2025) The Lowitja Institute. Available at https:\/\/www.lowitja.org.au\/"},{"issue":"7","key":"2026062519564422300_R48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation.","volume":"169","author":"Tricco","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"2026062519564422300_R49","unstructured":"Turning Point (2025) Time to rethink addiction. Turning Point. Available at https:\/\/www.turningpoint.org.au\/"},{"key":"2026062519564422300_R50","unstructured":"Veritas Heath Innovation (2017) Covidence systematic review software. Veritas Heath Innovation, Melbourne, Australia. p. 680."},{"issue":"1","key":"2026062519564422300_R51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11469-018-9936-2","article-title":"A narrative review of pharmacotherapy treatment for opioid addiction and application in a community-based model in Victoria, Australia.","volume":"18","author":"Vishwanath","year":"2020","journal-title":"International Journal of Mental Health and Addiction"},{"key":"2026062519564422300_R52","unstructured":"Ward P, Mattick R (2005) Health care utilisation and costs under the commonwealth medicare benefit scheme by methadone maintenance treatment patients in NSW. NDARC, UoNSW National Drug and Alcohol Research Centre, Sydney. Available at https:\/\/archive-ndarc.med.unsw.edu.au\/sites\/default\/files\/ndarc\/resources\/TR.240.pdf"},{"issue":"3","key":"2026062519564422300_R53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.18773\/austprescr.2025.028","article-title":"Medicines used in the treatment of opioid dependence.","volume":"48","author":"Wilson","year":"2025","journal-title":"Australian Prescriber"},{"issue":"2","key":"2026062519564422300_R54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1071\/PY20197","article-title":"Feasibility and outcomes of a general practice and specialist alcohol and other drug collaborative care program in Sydney, Australia.","volume":"28","author":"Wilson","year":"2022","journal-title":"Australian Journal of Primary Health"},{"issue":"1","key":"2026062519564422300_R55","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02474-6","article-title":"Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study using the theory of Planned Behaviour.","volume":"25","author":"Wilson","year":"2024","journal-title":"BMC Primary Care"},{"key":"2026062519564422300_R56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/00914509241309109","article-title":"\u201cThe Whole Structure Is Knackered, It Could Still Explode, It Really Could\u201d: a mixed methods study of initiatives to increase general practitioner prescribing in an opioid dependence treatment program from 1970 to 2022 in New South Wales, Australia.","volume":"52","author":"Wilson","year":"2025","journal-title":"Contemporary Drug Problems"}],"container-title":["Australian Journal of Primary Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/py\/article-pdf\/doi\/10.1071\/PY25274\/1882144\/py25274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/py\/article-pdf\/doi\/10.1071\/PY25274\/1882144\/py25274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:56:54Z","timestamp":1782431814000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/py\/article\/32\/4\/PY25274\/273087\/A-scoping-review-of-opioid-agonist-treatment-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8,17]]}},"URL":"https:\/\/doi.org\/10.1071\/py25274","relation":{},"ISSN":["1448-7527","1836-7399"],"issn-type":[{"value":"1448-7527","type":"print"},{"value":"1836-7399","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"PY25274"}}